688767.SHG Hangzhou Biotest Biotech Co Ltd

Healthcare Biotechnology Shanghai Stock Exchange
38.66 CNY
Close of Nov 5, 2026
29.84 50.04
Market cap
CNY 5.77B
P/E
429.6x
P/B
2.47x
ROE
-1.5%
Dividend yield
2.77%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688767.SHG undervalued?

Graham number

The Graham number of Hangzhou Biotest Biotech Co Ltd cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Hangzhou Biotest Biotech Co Ltd fundamental analysis

No fundamental analysis for Hangzhou Biotest Biotech Co Ltd yet.

Hangzhou Biotest Biotech Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Hangzhou Biotest Biotech Co Ltd

Hangzhou Biotest Biotech Co.,Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of in vitro diagnostic reagents in China and internationally. The company offers point-of-care testing rapid diagnostic reagents for drug abuse, infectious disease, fertility health, tumor market/oncology, cardiology market, veterinary, inflammation, and other testing. It also provides microfluidic immunofluorescence analysis systems; and Dia…

Full company profile